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Abstract: Two low oxygen sensors, Egl nine homolog 1 (EGLN1) and hypoxia-inducible 
factor 1-α inhibitor (HIF-1AN), play pivotal roles in the regulation of HIF-1α, and high 
altitude adaption may be involved in the pathology of acute mountain sickness (AMS). Here, 
we aimed to analyze single nucleotide polymorphisms (SNPs) in the untranslated regions of 
the EGLN1 and HIF-1AN genes and SNPs chosen from a genome-wide adaptation study  
of the Han Chinese population. To assess the association between EGLN1 and HIF-1AN 
SNPs and AMS in a Han Chinese population, a case–control study was performed including  
190 patients and 190 controls. In total, thirteen SNPs were genotyped using the 
MassARRAY® MALDI-TOF system. Multiple genetic models were tested; The Akaike’s 
information criterion (AIC) and Bayesian information criterion (BIC) values indicated  
that the dominant model may serve as the best-fit model for rs12406290 and rs2153364 of 
significant difference. However, these data were not significant after Bonferroni correction. 
No significant association was noted between AMS and rs12757362, rs1339894, rs1361384, 
rs2009873, rs2739513 or rs2486729 before and after Bonferroni correction. Further 
haplotype analyses indicated the presence of two blocks in EGLN1; one block consists  
of rs12406290-rs2153364, located upstream of the EGLN1 gene. Carriers of the “GG” 
haplotype of rs12406290-rs2153364 exhibited an increased risk of AMS after adjustments  
for age and smoking status. However, no significant association was observed among HIF-1AN  
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3'-untranslated region (3'-UTR) polymorphisms, haplotype and AMS. Our study indicates that 
variants in the EGLN1 5'-UTR influence the susceptibility to AMS in a Han Chinese population. 
Keywords: acute mountain sickness; Egl nine homolog 1 (EGLN1); hypoxia-inducible 
factor 1-α inhibitor (HIF-1AN); single nucleotide polymorphism; haplotype 
 
1. Introduction 
Acute ascent to high-altitude environments can result in a medical condition referred to as acute 
mountain sickness (AMS) in accordance with Lake Louise score system (LLss) [1]. In China, millions 
of people travel to high altitudes for recreation, work and pilgrimage; therefore, many people are at  
risk of developing AMS. However, individuals, families and populations differ in their capacity to cope 
with the challenge [2]. AMS has become a general complaint that affects the ability to work at high 
altitudes. Unacclimatized people may even develop high-altitude cerebral edema (HACE), a lethal 
encephalopathic disease. 
Although the pathology of AMS is not clear, hypobaric hypoxia serves as the primary etiology.  
Low oxygen concentrations inhibit hydroxylase activity and increase hypoxia-inducible factor-1α  
(HIF-1α) levels. HIF-1α accumulation and the subsequent up-regulation of vascular endothelial  
growth factor (VEGF) potentially contribute to basement membrane damage, and exaggerated edema 
might be involved in the pathophysiological process of AMS [3]. Two oxygen sensors, prolyl 
hydroxylase domain protein 2 (PHD2), also known as Egl nine homolog 1 (EGLN1), and factor 
inhibiting HIF-1α (FIH-1), also known as hypoxia-inducible factor 1-α inhibitor (HIF-1AN), play pivotal 
roles in HIF-1α pathway regulation. 
EGLN1 is a 46-kDa enzyme that consists of two functional domain, N-terminal domain and C-terminal 
domain. N-terminal domain is homologous to MYND zinc finger whereas C-terminal domain is homologous 
to 2-oxoglutarate dioxygenases. EGLN1 hydroxylates von Hippel-Lindau tumor-suppressor protein 
(VHL) Pro402 or Pro564, which allows HIF-1α to bind to the VHL. VHL interacts with the protein elongin 
C and subsequently ubiquitinates HIF-1α by recruiting an E3 ubiquitin-protein ligase complex. Thereafter, 
HIF-1α is targeted to the 26S proteasome for degradation [4]. HIF-1AN hydroxylates the Asn803 of  
HIF-1α and inhibits its interaction with the co-activator p300, which affects transcription of the 
downstream VEGF gene [4]. 
The reduced frequency of AMS in highlanders (HL) suggests that lowlanders (LL) are considerably 
more susceptible to AMS [5,6]. Genes that are associated with high altitude adaptation could influence 
AMS, as suggested by Wu et al. [6]. Evidence of genetic adaptation at different altitudes was recently 
provided by genome-wide investigations in HL and LL populations [7–9] and these investigations indicated 
that the EGLN1 and HIF-1AN genes could be involved in AMS. Therefore, polymorphisms in these genes 
may explain inter-individual differences in AMS. Pharmaceuticals, such as dexamethasone [10] have been 
identified that prophylactically treat AMS symptoms. The identification of individuals who have a genetic 
predisposition for AMS would be beneficial for decision-making regarding prophylactic drug use. 
The untranslated regions (UTRs) of eukaryotic genes contain regulatory regions. The 5' untranslated 
regions (5'-UTRs) influence the efficiency of translation and even have post-transcriptional effects, 
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including effects on mRNA stability and folding [11]. Therefore, sequence variations in 5'-UTR introns 
may affect gene expression. SNPs located in the 3'-UTR may affect the binding affinities of miRNAs 
for their target mRNAs [12], thus affecting the expression and function of the target gene. In the present 
case-control study, we attempted to determine whether variants of the EGLN1 and HIF-1AN genes, either 
previously identified in high altitude adaption study [13] or our currently selected in the UTRs, are 
associated with susceptibility to AMS. 
Since AMS happens mostly in a population acutely exposed to hypoxic environment, we recruited male 
Han Chinese volunteers who had been living at low altitudes, without recent high altitude exposure history. 
These subjects took the flights from 500 m (Chengdu in Sichuan province) to 3700 m (Lhasa) within 2 h. 
2. Results 
2.1. Characteristics of the Study Population 
A total of 380 DNA samples were genotyped, including 190 AMS patients and 190 controls.  
The characteristics of the study populations are shown in Table 1. No significant differences in age, 
height, weight, smoking rate or heart rate were noted between the AMS+ and AMS− group. However, 
SaO2 significantly differed between the AMS+ and AMS− groups (Table 1). 
Table 1. Demographic characteristics and physiological parameters of study population. 
Demographic Characteristics and Physiological Parameters AMS+ AMS− p Value
Age (year) 22.7 ± 3.5 22.9 ± 3.8 0.840 
Height (cm) 171.7 ± 4.9 171.7 ± 4.8 0.940 
Weight (kg) 64.7 ± 10.4 64.7 ± 10.4 0.830 
Smoking rate (%) 49.5 53.1 0.472 
Heart rate (bpm) 86.5 ± 12.9 84.7 ± 12.4 0.156 
SaO2 (%) 88.1 ± 2.90 88.8 ± 2.98 0.013 * 
bpm: beat per minute, * p < 0.05 
2.2. Genotyping of Target Single Nucleotide Polymorphisms (SNPs) 
The genotyping success rates of four target SNPs ranged from 98.7% to 100% in this study. Basic 
information regarding the SNPs in cases and controls is presented in Table 2. Of these SNPs, 
rs12757362, rs1339894 and rs1361384 exhibited very low minor allele frequencies (MAF) and were 
excluded from further analyses. 
2.3. Genetic Models of the Egl Nine Homolog 1 (EGLN1) and Hypoxia-Inducible Factor 1-α Inhibitor 
(HIF-1AN) Genes and the Risk of Acute Mountain Sickness (AMS) 
AMS is a complex disease and its mode of genetic inheritance is not clear. Codominant, dominant, 
recessive, overdominant and additive genetic models were applied to assess the association of SNPs within 
or near the HIF-1AN and EGLN1 genes with the risk of AMS using SNPStats software. We found that 
rs12406290 and rs2153364 in the 5'-UTR of the EGLN1 gene were associated with AMS risk (Table 3). 
The genetic models of the other polymorphisms are shown in Table 1 in the supplementary material. 
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Table 2. Basic single nucleotide polymorphism (SNP) information. 
rs Number Gene Name Allele Chromosome Position MAF HWE p 
rs1054399 HIF-1AN C/T Chr10:100552808 0.185 0.187 
rs11190613 HIF-1AN C/T Chr10:100554240 0.187 0.188 
rs11292 HIF-1AN C/T Chr10:100553850 0.187 0.188 
rs11816840 HIF-1AN C/G Chr10:100549463 0.182 0.188 
rs3750633 HIF-1AN A/G Chr10:100548457 0.187 0.188 
rs12406290 EGLN1 A/G Chr 1:231423480 0.460 0.378 
rs12757362 EGLN1 C/G Chr 1:231426746 0.060 1.000 
rs1339894 EGLN1 A/G Chr 1:231424811 0.001 1.000 
rs1361384 EGLN1 A/G Chr 1:231424487 0.005 0.970 
rs2009873 EGLN1 A/G Chr 1:231363490 0.420 0.487 
rs2153364 EGLN1 A/G Chr 1:231424474 0.530 0.532 
rs2486729 EGLN1 A/G Chr 1:231399838 0.420 0.302 
rs2739513 EGLN1 A/G Chr 1:231379455 0.430 0.541 
MAF: Minor allele frequency; HWE: Hardy-Weinberg equilibrium. 
Table 3. Single nucleotide polymorphism genetic models and analyses of the association 
between SNPs and acute mountain sickness (AMS) adjusted for age and smoking status. 
SNP Number Model Genotype AMS+ [n (%)] AMS− [n (%)] OR (95% CI) p-Value AIC BIC 
rs12406290 
Codominant 
AA 65 (34.6) 42 (22.7) 1.00 – – – 
AG 86 (45.7) 96 (51.9) 1.74 (1.07–2.84) – – – 
GG 37 (19.7) 47 (25.4) 1.91 (1.06–3.41) 0.04 522.9 554.3 
Dominant 
AA 65 (34.6) 42 (22.7) 1.00 – – – 
AG + GG 123 (65.4) 143 (77.3) 1.79 (1.13–2.84) 0.012 * 521 548.5 
Recessive 
AA + AG 151 (80.3) 138 (74.6) 1.00 – – – 
GG 37 (19.7) 47 (25.4) 1.34 (0.82–2.19) 0.24 526 553.5 
Overdominant 
AA + GG 102 (54.3) 89 (48.1) 1.00 – – – 
AG 86 (45.7) 96 (51.9) 1.31 (0.87–1.97) 0.19 525.7 553.1 
Log-additive – – – 1.40 (1.05–1.87) 0.022 522.1 549.6 
rs2153364 
Codominant 
AA 63 (33.5) 38 (21.1) 1.00 – – – 
AG 88 (46.8) 95 (52.8) 1.85 (1.12–3.05) – – – 
GG 37 (19.7) 47 (26.1) 2.14 (1.18–3.88) 0.019 514.4 545.6 
Dominant 
AA 63 (33.5) 38 (21.1) 1.00 – – – 
AG + GG 125 (66.5) 142 (78.9) 1.94 (1.20–3.11) 0.0057 * 512.7 540 
Recessive 
AA + AG 151 (80.3) 133 (73.9) 1.00 – – – 
GG 37 (19.7) 47 (26.1) 1.43 (0.88–2.34) 0.15 518.2 545.6 
Overdominant 
AA + GG 100 (53.2) 85 (47.2) 1.00 – – – 
AG 88 (46.8) 95 (52.8) 1.30 (0.86–1.96) 0.22 518.8 546.1 
Log-additive – – – 1.47 (1.10–1.98) 0.0095 513.6 540.9 
Numbers and frequencies of AMS+ or AMS− in each genotype were shown. AIC: Akaike’s information 
criterion; BIC: Bayesian information criterion. * Best-fit model p-value. 
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Under the codominant model, the genotypes “AG” (OR = 1.74; 95% CI, 1.07–2.84; p = 0.04) and “GG” 
(OR = 1.91; 95% CI, 1.06–3.41; p = 0.014) of rs12406290 were associated with an increased AMS  
risk. Under the dominant model, the “AG + GG” genotype of rs12406290 was associated with  
an increased AMS risk (OR = 1.79; 95% CI, 1.13–2.84; p = 0.012). In the log-additive model, rs12406290 
was associated with an increased risk of AMS (OR = 1.40; 95% CI, 1.05–1.87; p = 0.022) (Table 3). 
Similarly, under the codominant model, the “AG” (OR = 1.85; 95% CI, 1.12–3.05; p = 0.019) and  
“GG” (OR = 2.14; 95% CI, 1.18–3.88; p = 0.019) genotypes of rs2153364 were associated with  
an increased AMS risk compared with the “AA” genotype. Under the dominant model, the “AG + GG” 
genotype of rs2153364 was associated with an increased AMS risk (OR = 1.94; 95% CI, 1.20–3.11;  
p = 0.0057). Under the log-additive model, rs2153364 was associated with an increased risk of AMS  
(OR = 1.47; 95% CI, 1.10–1.98; p = 0.0095) (Table 3). 
The model with the lowest AIC and BIC values for a given polymorphism was considered the  
best-fit model. The AIC and BIC values indicated that the dominant model may serve as the best-fit 
model of rs12406290 and rs2153364 (Table 3). However, these values were not significant after 
Bonferroni correction (pcorrection = 0.05/13 = 0.0038). 
2.4. HIF-1AN and EGLN1 Haplotypes and the Risk of AMS 
The linkage disequilibrium (LD) coefficients were calculated using the Gabriel algorithm [14]. The 
results indicated that there were two LD blocks in the EGLN1 gene and one LD block in the HIF-1AN 
gene. Block 1 consisted of rs2009873-rs2739513 (Figure 1). Two common haplotypes (frequencies of 
≥0.05 for each) with a cumulative frequency of 0.991 were identified. No significant difference was 
observed between the two main haplotypes (Table 4). Block 2 consisted of rs12406290-rs2153364, 
which is located upstream of the EGLN1 gene (Figure 1). Two common haplotypes (frequencies of ≥0.05 
for each) with a cumulative frequency of 0.993 were identified in block 2. Carriers of the “GG” haplotype 
exhibited an increased risk of AMS after adjusting for age and smoking status (OR = 1.38; 95% CI, 
1.04–1.85; p = 0.029) (Table 4). Block 3 consisted of rs1054399, rs11190613, rs11292, rs11816840 and 
rs3750633 in the 3'-UTR region of the HIF-1AN gene (Figure 1). Two common haplotypes (frequencies 
≥0.05 for each) with a cumulative frequency of 1 were identified. No significant difference was observed 
between the two haplotypes after adjusting for age and smoking status (Table 4). 
The LD plot was generated using genotyping data from this study and Haploview 4.2 software.  
The correlation between two SNPs is indicated by the gray scale (a darker color indicates a strong 
correlation) by pairwise r2 values, and the pairwise D’ values are given as the percentage in each cell 
(cell in pure black indicates D’ = 1.00). Block 1 was formed by rs2009873-rs2739513. Block 2 was 
formed by rs12406290-rs2153364, which are located upstream of the EGLN1 gene. Block 3 consists of 
rs1054399, rs11190613, rs11292, rs11816840 and rs3750633, which are located in the 3'-UTR of the 
HIF-1AN gene. 
3. Discussion 
In the present study, 13 SNPs in two low-oxygen sensor genes that regulate HIF-1α were genotyped. 
Our study determined that rs12406290 and rs2153364 in the 5'-UTR of the EGLN1 gene are strongly 
associated with AMS risk after adjusting for age and smoking status, even though after Bonferroni 
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correction the results turned out to be insignificant. AIC and BIC analyses indicated that a dominant 
model may serve as the best-fit genetic model for these SNPs. Further haplotype analyses found that the 
rs12406290-rs2153364 haplotype was associated with AMS. The results of the current study provide 
novel information about EGLN1 under hypobaric hypoxia that might reveal a role for this gene in AMS. 
No significant association was found between polymorphisms in the HIF-1AN 3'-UTR and AMS before 
and after Bonferroni correction. The prevalence of risk genotypes and haplotypes in AMS supports the 
hypothesis regarding the involvement of common genetic factors. 
Table 4. Haplotype frequencies and the association with AMS risk adjusted for age and 
smoking status. 






Odds Ratio  
95% CI 
EGLN1 
Global haplotype association test p = 0.004 c 
Block 1 
AA 60.9 54.75 – 1.00 b 
GG 39.1 43.63 0.12 1.25 (0.94–1.66) 
Global haplotype association test p = 0.036 c 
Block 2 
AA 56.83 48.92 – 1.00 b 
GG 42.1 50.79 0.029 * 1.38 (1.04–1.85) 
HIF-1AN 
Global haplotype association test p = 0.7 c 
Block 3 
CTTGG 90.26 90.63 – 1.00 b 
TCACA 9.74 9.37 0.7 0.91 (0.57–1.46) 
Frequency of each haplotype block was shown in percentage. a, Haplotypes with frequency ≥0.05 were shown; 
b, Reference haplotype; c, A global test was performed for the null hypothesis such that no haplotype was 
associated with the risk of AMS. The analyses were adjusted by age and smoking status. * p < 0.05; Block 1 
consisted of rs2009873-rs2739513; Block 2 consisted of rs12406290-rs2153364; Block 3 consisted of 
rs1054399, rs11190613, rs11292, rs11816840 and rs3750633. 
Figure 1. Linkage disequilibrium (LD) plot constructed by Haploview 4.2 software. 
 
At higher altitudes, the atmospheric mass at the measurement point indexed to sea level is reduced, 
which results in decreased barometric pressure. Here, a decline in the partial pressure of oxygen was 
observed. AMS commonly develops in individuals who arrive at altitudes greater than 2500 m above 
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sea level and is accompanied by a decrease in SaO2 [15]. Our results also indicate that AMS patients 
have a lower SaO2 at plateau. HIF-1α subunits have a short half-life under normoxic conditions,  
as HIF-1α is synthesized and degraded continuously in cells. However, the degradation of HIF-1α is 
reduced under hypoxia [16]. HIF-1α accumulation and subsequent up-regulation of VEGF could 
contribute to basement membrane damage, and exaggerated edema is involved in the pathophysiological 
process, as suggested by Wilson et al. [3]. A recent study indicates that dexamethasone impairs  
HIF-1α function and the expression of its target genes [17]. This finding may explain the fact that the 
prophylactic use of dexamethasone efficiently reduces the occurrence of AMS. 
Studies have revealed that EGLN1 activity is reduced under hypoxic conditions by substrate 
limitation [18] or catalytic center inhibition [19]; thus, EGLN1 plays a key role in HIF-1α regulation and 
downstream gene expression. Numerous studies have revealed that EGLN1 gene expression is associated 
with high altitude adaption in various ethnicities at different plateaus [7,8,13,20–21]. An in vitro study 
demonstrated that the PHD2 haplotype D4E/C127S dramatically diminished the interaction between 
PHD2 and p23, leading to impaired PHD2-mediated down-regulation of the HIF pathway [22]. In 
addition, the Asp4Glu; Cys127Ser variant promotes increased HIF-1 degradation under hypoxic 
conditions [23]. A case-control study with a relatively small sample size revealed that two common 
EGLN1 variants are associated with AMS. Our present study suggests that the rs12406290 and 
rs2153364 SNPs located in the 5'-UTR of EGLN1 are associated with AMS in a Han Chinese population. 
At a type I error probability of 0.05, the statistical power to detect a relative risk of 2 compared with  
the AMS+ group was sufficient for rs12406290 and rs2153364. Thus, variation in the 5'-UTR may  
affect the level of gene expression and protein translation. The online software programs FuncPred 
(http://snpinfo.niehs.nih.gov/) and F-SNP (http://compbio.cs.queensu.ca/F-SNP/) were used to predict 
the functional effects of these two SNPs. The functional prediction results indicated that rs12406290  
and rs2153364 are both located at the presumed transcription factor binding site of the EGLN1 gene.  
We further used TFSEARCH Search software (http://www.cbrc.jp/research/db/TFSEARCH.html) to 
identify TFs. Our analysis revealed that the rs12406290 and rs2153364 polymorphisms were located at 
binding sites for HSG and c-Ets, respectively. Thus, rs12567209, rs2153364 and rs12406290-rs2153364 
haplotypes may alter transcription factor binding sites and affect EGLN1 gene expression to influence 
HIF-1α regulation. 
HIF-1AN hydroxylates HIF-1α and inhibits its interaction with p300, thus regulating the HIF 
pathway. Loss of HIF-1AN significantly alters the physiological response and causes a hyper-metabolic 
phenotype [24]. Additionally, the response of the brain to altitude is crucial due to its high rate of oxygen 
consumption. A decrease in the partial pressure of inhaled oxygen at high altitudes in combination with 
a hyper-metabolic phenotype might induce AMS. HIF-1AN is associated with advanced prostate cancer 
due to its regulatory effects on HIF-1 [25]. miRNAs that target FIH-1 have been shown to regulate 
metabolism [26]. We therefore genotyped 3'-UTR variants to determine their relationship to AMS. 
Further analyses with the online software program MirSNP (http://cmbi.bjmu.edu.cn/mirsnp) indicate 
that rs11292 and rs11816840 are located at a predicted miRNA binding site. However, no associations 
were identified between AMS and rs1054399, rs11190613, rs11292, rs11816840 or rs3750633. 
It is possible that the results of the current study may only be applied to young males because the 
study subjects were all young males. Our study is the first to demonstrate that the rs12406290, rs2153364 
and rs12406290-rs2153364 haplotypes in the 5'-UTR of the EGLN1 gene are associated with AMS risk 
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in a Han Chinese population. These results further demonstrate that genes associated with high altitude 
adaptation may also be involved in AMS. Further functional characterization of the effects of the 
polymorphisms on transcription factor binding and EGLN1 expression may elucidate the underlying 
mechanisms involved in AMS etiology. Prophylactic drug use may be beneficial for individuals with 
“G” alleles of rs12406290 and rs2153364 and a “GG” haplotype before they ascend to high altitudes. 
4. Methods 
4.1. Subjects 
The subjects included 190 patients with AMS and 190 healthy Han Chinese controls randomly chosen 
from 850 volunteers who ascended from 500 m (Chengdu in Sichuan province) to 3700 m (Lhasa) in  
2 h by plane. All included subjects were unrelated males who had lived at low altitudes prior to being 
recruited during the period from 21 June to 25 June 2012, as previously described [27]. Subjects who 
were exposed to altitudes ≥2500 m in the past 6 months, subjects who were taking acetazolamide or 
steroids for AMS prophylaxis and subjects who were diagnosed with psychological or neurological 
disorders were excluded. Venous blood (5 mL) was obtained from all individuals included in the  
study for future genetic analysis, and written informed consent was obtained from all subjects. The study 
was approved by the Ethics Committee of Xinqiao Hospital, Third Military Medical University 
(identification code: 2012014 approved on 9 May 2012). 
4.2. AMS Score and Physical Signs 
AMS scores were obtained using the Lake Louise scoring system (LLss) within 24 h after the 
participants arrived at 3700 m. The subjects were then divided into AMS+ and AMS− individuals in 
accordance with the LLSS results. Smoking status was classified as follows: 0 = no smoking history,  
1 = past smoking history and 2 = present smoking. Physiological signs of HR and BP were measured 
using a sphygmomanometer (HEM-6200, OMRON Healthcare Ltd., Kyoto, Japan). SaO2 was measured 
using a Pulse Oximeter (NONIN-9550, Nonin Onyx, Plymouth, MN, USA). 
4.3. SNP Selection 
We performed a search on website (http://www.ncbi.nlm.nih.gov/projects/SNP/) and found that  
HIF-1AN exhibits a wide range of 3'-UTR sequences. We selected rs1054399, rs11190613, rs11292, 
rs11816840 and rs3750633 SNPs, which located in the HIF-1AN 3'-UTR with Minor Allele Frequency 
(MAF) ≥0.1. Similarly, we selected rs12406290, rs12757362, rs1339894, rs2153364 and rs1361384 SNPs 
at EGLN1 5'-UTR, and rs2009873 near EGLN1 3'-UTR, based on MAF values ≥0.1. A genome-wide 
association study for high altitude adaption [13] indicates that six EGLN1 intron SNPs (rs2066140, 
rs2739513, rs2486736, rs480902, rs2790882 and rs2486729) are listed in the top 0.01% of highly 
differentiated SNPs between Tibetans and Han Chinese. Because they are all in linkage disequilibrium 
(LD) (threshold r2 ≥ 0.8) in CHB by tagger-pairwise algorithm in Hapmap (http://hapmap.ncbi.nlm.nih.gov/), 
we selected two SNPs (rs2739513 and rs2486729) as tag SNPs. 
  




Genomic DNA was extracted from whole blood in accordance with the instructions provided  
with the PAXgene Blood DNA kit (Qiagen, Hilden, Germany). Genomic DNA samples were stored at 
−20 °C until analysis. PCR primer pairs were designed using Sequenom® Assay Design software 
(version 3.1, Sequenom Inc., San Diego, CA, USA) and synthesized by Sangon Biotech (Shanghai, 
China; see Table S1). Genotyping was performed using the MassARRAY® MALDI-TOF System 
(Sequenom Inc., San Diego, CA, USA). For quality control, two non-template controls were used in the 
plate and chip. 
4.5. Data Analysis 
SHEsis (http://analysis.biox.cn/myAnalysis.php) online software was used to confirm Hardy–Weinberg 
equilibrium and allele frequencies via Chi-square tests. Differences in the physiological parameters of the 
study population were assessed by t-tests as appropriate. Analyses of genotype distributions adjusted for 
age and smoking status were performed by unconditional logistic regression. AIC and BIC values were 
used to determine the best-fit model for each SNP. LD analysis and haplotype construction using 
Haploview 4.2 [28] software were subsequently employed to further analyze the association of different 
haplotypes with the risk of AMS. The results were analyzed using SPSS 16.0 (SPSS Inc., Chicago, IL, 
USA) and SNPStats online software (http://bioinfo.iconcologia.net/SNPstats) [29]. Power calculations 
were performed using power and sample size calculations [30]. 
5. Conclusions 
Our study indicates that variants in the EGLN1 5'-UTR influence the susceptibility to AMS in a  
Han Chinese population. 
Supplementary Materials 
Supplementary materials can be found at http://www.mdpi.com/1422-0067/15/12/21777/s1. 
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